Pharmaceutical Supply – Dexamethasone Tablets

The contract is for the supply of Dexamethasone Tablets identified by NSN 6505010450451, requiring packaging that complies with federal medical logistics standards to ensure proper handling, traceability, and readiness for military medical use. The pharmaceutical product is intended for distribution through the Department of Defense’s medical supply chain, with performance centered at Fort Bragg, North Carolina, under the oversight of the Medical Supply Chain Pharm FSA. The solicitation, issued as a subcontract under NAICS code 325412 for pharmaceutical manufacturing, was posted on July 23, 2026, with responses due by July 29, 2026, indicating a narrow window for qualified suppliers to submit bids. The procurement is part of a broader effort to maintain consistent, secure, and standards-compliant inventory of critical medications within the military healthcare system, and all deliveries must align with stringent DoD logistics protocols to support operational readiness and patient care.